Two spinoff companies share grants with U-M for medical projects
The U-M Nanotechnology Institute for Medicine and Biological Sciences (MNIMBS) will collaborate with a U-M spinoff company to develop a safe and effective Respiratory Syncytial Virus intranasal vaccine.
Approximately one-third of a nearly $6 million grant, awarded by the Bill and Melinda Gates Foundation to the Ann Arbor-based NanoBio Corp., will be subcontracted to MNIMBS in exchange for a two-year commitment to the project. Click here to read more.
Meanwhile, Cielo MedSolutions, another Ann Arbor-based U-M spinoff, has received a $1.3 million National Cancer Institute grant to develop and prototype along with the U-M Health System a next-generation clinical quality-management solution. Click here to read more.